NEW YORK(GenomeWeb) – Melanoma test development firm DermTech has raised $2.4 million. 

DermTech disclosed the financing in a document filed with the US Securities and Exchange Commission earlier this week. In an email, DermTech CFO and Treasurer Steven Kemper told GenomeWeb that participants in the private financing round included existing investors. He added that the La Jolla, Calif.-based firm is launching its pigmented lesion assay and is currently testing the assay with certain US dermatologists with plans for a broader launch in the second half of this year. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.